 The objectives of this study are to assess the effects of 4 gd prescription omega-3 acid ethyl esters POM3, compared with a placebo, on indices of insulin sensitivity and secretion, as well as aspects of the fasting and postprandial lipid and lipoprotein profiles, in subjects with hypertriglyceridemia. 